Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 165

1.

Inhibition of filovirus replication by the zinc finger antiviral protein.

Müller S, Möller P, Bick MJ, Wurr S, Becker S, Günther S, Kümmerer BM.

J Virol. 2007 Mar;81(5):2391-400. Epub 2006 Dec 20.

2.

Infectious Lassa virus, but not filoviruses, is restricted by BST-2/tetherin.

Radoshitzky SR, Dong L, Chi X, Clester JC, Retterer C, Spurgers K, Kuhn JH, Sandwick S, Ruthel G, Kota K, Boltz D, Warren T, Kranzusch PJ, Whelan SP, Bavari S.

J Virol. 2010 Oct;84(20):10569-80. doi: 10.1128/JVI.00103-10. Epub 2010 Aug 4.

3.

High-throughput, luciferase-based reverse genetics systems for identifying inhibitors of Marburg and Ebola viruses.

Uebelhoer LS, Albariño CG, McMullan LK, Chakrabarti AK, Vincent JP, Nichol ST, Towner JS.

Antiviral Res. 2014 Jun;106:86-94. doi: 10.1016/j.antiviral.2014.03.018. Epub 2014 Apr 5.

4.

Expression of the zinc-finger antiviral protein inhibits alphavirus replication.

Bick MJ, Carroll JW, Gao G, Goff SP, Rice CM, MacDonald MR.

J Virol. 2003 Nov;77(21):11555-62.

5.

The zinc finger antiviral protein directly binds to specific viral mRNAs through the CCCH zinc finger motifs.

Guo X, Carroll JW, Macdonald MR, Goff SP, Gao G.

J Virol. 2004 Dec;78(23):12781-7.

6.

Deep sequencing identifies noncanonical editing of Ebola and Marburg virus RNAs in infected cells.

Shabman RS, Jabado OJ, Mire CE, Stockwell TB, Edwards M, Mahajan M, Geisbert TW, Basler CF.

MBio. 2014 Nov 4;5(6):e02011. doi: 10.1128/mBio.02011-14.

7.

Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists.

Cheng H, Lear-Rooney CM, Johansen L, Varhegyi E, Chen ZW, Olinger GG, Rong L.

J Virol. 2015 Oct;89(19):9932-8. doi: 10.1128/JVI.01337-15. Epub 2015 Jul 22.

8.

Rab9 GTPase is required for replication of human immunodeficiency virus type 1, filoviruses, and measles virus.

Murray JL, Mavrakis M, McDonald NJ, Yilla M, Sheng J, Bellini WJ, Zhao L, Le Doux JM, Shaw MW, Luo CC, Lippincott-Schwartz J, Sanchez A, Rubin DH, Hodge TW.

J Virol. 2005 Sep;79(18):11742-51.

9.

Expression and RNA-binding of human zinc-finger antiviral protein.

Jeong MS, Kim EJ, Jang SB.

Biochem Biophys Res Commun. 2010 Jun 4;396(3):696-702. doi: 10.1016/j.bbrc.2010.04.164. Epub 2010 May 6.

PMID:
20451500
10.

Rescue of Ebola virus from cDNA using heterologous support proteins.

Theriault S, Groseth A, Neumann G, Kawaoka Y, Feldmann H.

Virus Res. 2004 Nov;106(1):43-50.

PMID:
15522446
11.

VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice.

Enterlein S, Warfield KL, Swenson DL, Stein DA, Smith JL, Gamble CS, Kroeker AD, Iversen PL, Bavari S, Mühlberger E.

Antimicrob Agents Chemother. 2006 Mar;50(3):984-93.

12.

Mutagenesis analysis of the zinc-finger antiviral protein.

Wang X, Lv F, Gao G.

Retrovirology. 2010 Mar 13;7:19. doi: 10.1186/1742-4690-7-19.

13.

Inhibition of hepatitis B virus replication by the host zinc finger antiviral protein.

Mao R, Nie H, Cai D, Zhang J, Liu H, Yan R, Cuconati A, Block TM, Guo JT, Guo H.

PLoS Pathog. 2013;9(7):e1003494. doi: 10.1371/journal.ppat.1003494. Epub 2013 Jul 11.

14.

Cathepsins B and L activate Ebola but not Marburg virus glycoproteins for efficient entry into cell lines and macrophages independent of TMPRSS2 expression.

Gnirss K, Kühl A, Karsten C, Glowacka I, Bertram S, Kaup F, Hofmann H, Pöhlmann S.

Virology. 2012 Mar 1;424(1):3-10. doi: 10.1016/j.virol.2011.11.031. Epub 2012 Jan 4.

15.

Role of EXT1 and Glycosaminoglycans in the Early Stage of Filovirus Entry.

O'Hearn A, Wang M, Cheng H, Lear-Rooney CM, Koning K, Rumschlag-Booms E, Varhegyi E, Olinger G, Rong L.

J Virol. 2015 May;89(10):5441-9. doi: 10.1128/JVI.03689-14. Epub 2015 Mar 4.

17.

Innate Immune Responses of Bat and Human Cells to Filoviruses: Commonalities and Distinctions.

Kuzmin IV, Schwarz TM, Ilinykh PA, Jordan I, Ksiazek TG, Sachidanandam R, Basler CF, Bukreyev A.

J Virol. 2017 Mar 29;91(8). pii: e02471-16. doi: 10.1128/JVI.02471-16. Print 2017 Apr 15.

18.

The Short Form of the Zinc Finger Antiviral Protein Inhibits Influenza A Virus Protein Expression and Is Antagonized by the Virus-Encoded NS1.

Tang Q, Wang X, Gao G.

J Virol. 2017 Jan 3;91(2). pii: e01909-16. doi: 10.1128/JVI.01909-16. Print 2017 Jan 15.

19.
20.

Genomic RNA editing and its impact on Ebola virus adaptation during serial passages in cell culture and infection of guinea pigs.

Volchkova VA, Dolnik O, Martinez MJ, Reynard O, Volchkov VE.

J Infect Dis. 2011 Nov;204 Suppl 3:S941-6. doi: 10.1093/infdis/jir321.

PMID:
21987773

Supplemental Content

Support Center